Tuberculosis and Respiratory Diseases

The Korean Academy of Tuberculosis and Respiratory Diseases (대한결핵및호흡기학회)
권호 표지

Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease

만성 폐쇄성 폐질환 환자에서 발생한 급성 호흡부전의 치료

  • Lee, Chang Hoon (Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine and Lung Institute, Seoul National University College of Medicine) ;
  • Yoo, Chul-Gyu (Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine and Lung Institute, Seoul National University College of Medicine)
  • 이창훈 (서울대학교 의과대학 내과학교실 및 폐 연구소) ;
  • 유철규 (서울대학교 의과대학 내과학교실 및 폐 연구소)
  • Published : 2005.11.30
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. The National Collaborating Centre for Chronic Conditions. Chronic obstructive lung disease: National clinical guideline on mamagement of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax 2004;59(Suppl 1):I232
  2. Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987;106:196-204 https://doi.org/10.7326/0003-4819-106-2-196
  3. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23:932-46 https://doi.org/10.1183/09031936.04.00014304
  4. National Institutes of Health. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease NHLBI/WHO workshop report updated 2004
  5. Johnson MK, Stevenson RD. Management of an acute exacerbation of COPD: are we ignoring the evidence? Thorax 2002;57(Suppl 2):ii15-23 https://doi.org/10.1136/thorax.57.1.15
  6. Connors AF Jr, Dawson NV, Thomas C, Harrell FE Jr, Desbiens N, Fulkerson WJ, et al. Outcomes follow-ing acute exacerbation of severe chronic obstructive lung disease. Am J Respir Crit Care Med 1996;154: 959-67 https://doi.org/10.1164/ajrccm.154.4.8887592
  7. Roberts CM, Lowe D, Bucknall CE, Ryland I, Kelly Y, Pearson MG. Clinical audit indicators of outcome following admission to hospital with acute exacerbation of chronic obstructive pulmonary disease. Thorax 2002;57: 137-41 https://doi.org/10.1136/thorax.57.2.137
  8. Garcia-Aymerich J, Monso E, Marrades RM, Escarrabill J, Felez MA, Sunyer J, et al. Risk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation. Am J Respir Crit Care Med 2001;164: 1002-7 https://doi.org/10.1164/ajrccm.164.6.2006012
  9. Roberts CM, Ryland I, Lowe D, Kelly Y, Bucknall CE, Pearson MG. Audit of acute admissions of COPD: standards of care and management in the hospital setting. Eur Respir J 2001;17:343-9 https://doi.org/10.1183/09031936.01.17303430
  10. Swinburn CR, Mould H, Stone TN, Corris PA, Gibson GJ. Symptomatic benefit of supplemental oxygen in hypoxemic patients with chronic lung disease. Am Rev Respir Dis 1991;143:913-5 https://doi.org/10.1164/ajrccm/143.5_Pt_1.913
  11. Warren PM, Flenley DC, Millar JS, Avery A. Respiratory failure revisited: acute exacerbations of chronic bronchitis between 1961-68 and 1970-76. Lancet 1980; 1:467-70
  12. Jeffrey AA, Warren PM, Flenley DC. Acute hypercapnic respiratory failure in patients with chronic obstructive lung disease: risk factors and use of guidelines for management. Thorax 1992;47:34-40 https://doi.org/10.1136/thx.47.1.34
  13. The COPD Guidelines Group of the Standards of Care Committee of the BTS. BTS guidelines for the management of chronic obstructive pulmonary disease. Thorax 1997;52(Suppl 5):S1-28 https://doi.org/10.1136/thx.52.1.1
  14. Bone RC, Pierce AK, Johnson RL Jr. Controlled oxygen administration in acute respiratory failure in chronic obstructive pulmonary disease: a reappraisal. Am J Med 1978;65:896-902 https://doi.org/10.1016/0002-9343(78)90740-4
  15. Costello RW, Liston R, McNicholas WT. Compliance at night with low flow oxygen therapy: a comparison of nasal cannulae and Venturi face masks. Thorax 1995;50:405-6 https://doi.org/10.1136/thx.50.4.405
  16. Karpel JP, Pesin J, Greenberg D, Gentry E. A comparison of the effects of ipratropium bromide and metaproterenol sulfate in acute exacerbations of COPD. Chest 1990;98:835-9 https://doi.org/10.1378/chest.98.4.835
  17. McCrory DC, Brown C, Gelfand SE, Bach PB. Management of acute exacerbations of COPD: a summary and appraisal of published evidence. Chest 2001;119: 1190-209 https://doi.org/10.1378/chest.119.4.1190
  18. Cydulka RK, Emerman CL. Effects of combined treatment with glycopyrrolate and albuterol in acute exacerbation of chronic obstructive pulmonary disease. Ann Emerg Med 1995;25:470-3 https://doi.org/10.1016/S0196-0644(95)70260-1
  19. Shrestha M, O'Brien T, Haddox R, Gourlay HS, Reed G. Decreased duration of emergency department treatment of chronic obstructive pulmonary disease exacerbations with the addition of ipratropium bromide to beta-agonist therapy. Ann Emerg Med 1991;20: 1206-9 https://doi.org/10.1016/S0196-0644(05)81472-6
  20. Patrick DM, Dales RE, Stark RM, Laliberte G, Dickinson G. Severe exacerbations of COPD and asthma: incremental benefit of adding ipratropium to usual therapy. Chest 1990;98:295-7 https://doi.org/10.1378/chest.98.2.295
  21. Moayyedi P, Congleton J, Page RL, Pearson SB, Muers MF. Comparison of nebulised salbutamol and ipratropium bromide with salbutamol alone in the treatment of chronic obstructive pulmonary disease. Thorax 1995;50:834-7 https://doi.org/10.1136/thx.50.8.834
  22. O'Driscoll BR, Taylor RJ, Horsley MG, Chambers DK, Bernstein A. Nebulised salbutamol with and without ipratropium bromide in acute airflow obstruction. Lancet 1989;1:1418-20
  23. Wrenn K, Slovis CM, Murphy F, Greenberg RS. Aminophylline therapy for acute bronchospastic disease in the emergency room. Ann Intern Med 1991;115: 241-7 https://doi.org/10.7326/0003-4819-115-4-241
  24. Seidenfeld JJ, Jones WN, Moss RE, Tremper J. Intravenous aminophylline in the treatment of acute bronchospastic exacerbations of chronic obstructive pulmonary disease. Ann Emerg Med 1984;13:248-52 https://doi.org/10.1016/S0196-0644(84)80472-2
  25. Rice KL, Leatherman JW, Duane PG, Snyder LS, Harmon KR, Abel J, et al. Aminophylline for acute exacerbations of chronic obstructive pulmonary disease: a controlled trial. Ann Intern Med 1987; 107:305-9 https://doi.org/10.7326/0003-4819-107-2-305
  26. Turner MO, Patel A, Ginsburg S, FitzGerald JM. Bronchodilator delivery in acute airflow obstruction: a meta-analysis. Arch Intern Med 1997;157:1736-44 https://doi.org/10.1001/archinte.157.15.1736
  27. Soto FJ, Varkey B. Evidence-based approach to acute exacerbations of COPD. Curr Opin Pulm Med 2003; 9:117-24 https://doi.org/10.1097/00063198-200303000-00005
  28. Niewoehner DE, Erbland ML, Deupree RH, Collins D, Gross NJ, Light RW, et al. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. N Engl J Med 1999;340:1941-7 https://doi.org/10.1056/NEJM199906243402502
  29. Davies L, Angus RM, Calverley PM. Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial. Lancet 1999; 354:456-60 https://doi.org/10.1016/S0140-6736(98)11326-0
  30. Bullard MJ, Liaw SJ, Tsai YH, Min HP. Early corticosteroid use in acute exacerbations of chronic airflow obstruction. Am J Emerg Med 1996;14:139-43 https://doi.org/10.1016/S0735-6757(96)90120-5
  31. Thompson WH, Nielson CP, Carvalho P, Charan NB, Crowley JJ. Controlled trial of oral prednisone in outpatients with acute COPD exacerbation. Am J Respir Crit Care Med 1996;154:407-12 https://doi.org/10.1164/ajrccm.154.2.8756814
  32. Emerman CL, Connors AF, Lukens TW, May ME, Effron D. A randomized controlled trial of methylpre-dnisolone in the emergency treatment of acute exacerbations of COPD. Chest 1989;95:563-7 https://doi.org/10.1378/chest.95.3.563
  33. Albert RK, Martin TR, Lewis SW. Controlled clinical trial of methylprednisolone in patients with chronic bronchitis and acute respiratory insufficiency. Ann Intern Med 1980;92:753-8 https://doi.org/10.7326/0003-4819-92-6-753
  34. Sayiner A, Aytemur ZA, Cirit M, Unsal I. Systemic glucocorticoids in severe exacerbations of COPD. Chest 2001;119:726-30 https://doi.org/10.1378/chest.119.3.726
  35. Bandi V, Apicella MA, Mason E, Murphy TF, Siddiqi A, Atmar RL, et al. Nontypeable Haemophilus influenzae in the lower respiratory tract of patients with chronic bronchitis. Am J Respir Crit Care Med 2001;164:2114-9 https://doi.org/10.1164/ajrccm.164.11.2104093
  36. Soler N, Torres A, Ewig S, Gonzalez J, Celis R, el Ebiary M, et al. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am J Respir Crit Care Med 1998;157:1498-505 https://doi.org/10.1164/ajrccm.157.5.9711044
  37. Miravitlles M, Espinosa C, Fernandez-Laso E, Martos JA, Maldonado JA, Gallego M. Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Chest 1999;116:40-6 https://doi.org/10.1378/chest.116.1.40
  38. Ball P. Epidemiology and treatment of chronic bronchitis and its exacerbations. Chest 1995;108:43S-52S https://doi.org/10.1378/chest.108.2_Supplement.43S
  39. Miravitlles M. Exacerbations of chronic obstructive pulmonary disease: when are bacteria important? Eur Respir J Suppl 2002;36:9S-19S
  40. Seemungal TA, Harper-Owen R, Bhowmik A, Jeffries DJ, Wedzicha JA. Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease. Eur Respir J 2000;16:677-83 https://doi.org/10.1034/j.1399-3003.2000.16d19.x
  41. Lieberman D, Lieberman D, Ben Yaakov M, Lazarovich Z, Hoffman S, Ohana B, et al. Infectious etiologies in acute exacerbation of COPD. Diagn Microbiol Infect Dis 2001;40:95-102 https://doi.org/10.1016/S0732-8893(01)00255-3
  42. Saint S, Bent S, Vittinghoff E, Grady D. Antibiotics in chronic obstructive pulmonary disease exacerbations: a meta-analysis. JAMA 1995;273:957-60 https://doi.org/10.1001/jama.273.12.957
  43. Stockley RA, O'Brien C, Pye A, Hill SL. Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD. Chest 2000;117:1638-45 https://doi.org/10.1378/chest.117.6.1638
  44. Brochard L, Mancebo J, Wysocki M, Lofaso F, Conti G, Rauss A, et al. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med 1995;333:817-22 https://doi.org/10.1056/NEJM199509283331301
  45. Plant PK, Owen JL, Elliott MW. Early use of noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial. Lancet 2000;355:1931-5 https://doi.org/10.1016/S0140-6736(00)02323-0
  46. Bott J, Carroll MP, Conway JH, Keilty SE, Ward EM, Brown AM, et al. Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease. Lancet 1993;341:1555-7 https://doi.org/10.1016/0140-6736(93)90696-E
  47. Kramer N, Meyer TJ, Meharg J, Cece RD, Hill NS. Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure. Am J Respir Crit Care Med 1995;151:1799-806 https://doi.org/10.1164/ajrccm.151.6.7767523
  48. Keenan SP, Kernerman PD, Cook DJ, Martin CM, McCormack D, Sibbald WJ. Effect of noninvasive positive pressure ventilation on mortality in patients admitted with acute respiratory failure: a meta-analysis. Crit Care Med 1997;25:1685-92 https://doi.org/10.1097/00003246-199710000-00018
  49. Wysocki M, Tric L, Wolff MA, Gertner J, Millet H, Herman B. Noninvasive pressure support ventilation in patients with acute respiratory failure. Chest 1993; 103:907-13 https://doi.org/10.1378/chest.103.3.907
  50. Jiang JS, Kao SJ, Wang SN. Effect of early application of biphasic positive airway pressure on the outcome of extubation in ventilator weaning. Respirology 1999;4: 161-5 https://doi.org/10.1046/j.1440-1843.1999.00168.x
  51. Gust R, Gottschalk A, Schmidt H, Bottiger BW, Bohrer H, Martin E. Effects of continuous (CPAP) and bilevel positive airway pressure (BiPAP) on extravascular lung water after extubation of the trachea in patients following coronary artery bypass grafting. Intensive Care Med 1996;22:1345-50 https://doi.org/10.1007/BF01709549
  52. Nava S, Ambrosino N, Clini E, Prato M, Orlando G, Vitacca M, et al. Noninvasive mechanical ventilation in the weaning of patients with respiratory failure due to chronic obstructive pulmonary disease: a randomized, controlled trial. Ann Intern Med 1998;128: 721-8 https://doi.org/10.7326/0003-4819-128-9-199805010-00004